Opko Renal, LLC
Records under this name other than the patents Opko Renal, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,906,410 | Oral Dosage Form of 25-Hydroxyvitamin D Formerly held In force · High confidence | In force | High confidence | |
| US 10,668,089 | Method of Treating and Preventing Secondary Hyperparathyroidism Formerly held In force · High confidence | In force | High confidence | |
| US 11,452,734 | Method of Treating and Preventing Secondary Hyperparathyroidism Formerly held In force · High confidence | In force | High confidence | |
| US 8,207,149 | Method for Treating Secondary Hyperparathyroidism in CKD Formerly held In force · High confidence | In force | High confidence | |
| US 8,778,373 | Methods for Controlled Release Oral Dosage of a Vitamin D Compound Formerly held In force · High confidence | In force | High confidence | |
| US 9,408,858 | Method for Treating Secondary Hyperparathyroidism in CKD Formerly held In force · High confidence | In force | High confidence | |
| US 9,498,486 | Method for Controlled Release Oral Dosage of a Vitamin D Compound Formerly held In force · High confidence | In force | High confidence | |
| US 9,918,940 | Methods for Controlled Release Oral Dosage of a Vitamin D Compound Formerly held In force · High confidence | In force | High confidence | |
| US 9,925,147 | Method for Treating Secondary Hyperparathyroidism in CKD Formerly held In force · High confidence | In force | High confidence | |
| US 11,154,509 | Methods for Controlled Release Oral Dosage of a Vitamin D Compound Formerly held In force · High confidence | In force | High confidence |